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ABSTRACT 
The current increase in the prevalence of nosocomial infections within the hospital environment despite adequate cleaning 
and disinfection can be said to be due to the following: (i) ineffectiveness of the various disinfectant formulations used in 
infection control on the various hospital equipments and wards; (ii) development of resistance to the various chemical 
disinfectant formulations been used in the hospitals by the various microorganisms.  
 
Ten bacteria isolates from different clinical specimens of hospitalized patients identified using standard bacteriological 
methods and found after screening to be resistant to two or more classes of the antibiotics: cephalosporins, quinolones, 
Betalactams, nitrofuran, macrolide and an aminoglycoside using the Kirby-Bauer method of disc diffusion test were used 
in this study.              These were subjected to susceptibility testing against three selected disinfectant formulations (Izal, 
Dettol and Jik) at the manufacturer’s dilutions and half the dilutions prescribed on their labels by using agar diffusion 
method. Out of these clinical isolates used in this study, 5 (50%) and 2 (20%) were resistant to manufacturer’s dilution 
and half the dilution of Dettol respectively, 9 (90%) and 6 (60%) to manufacturer’s dilution and half the dilution of Izal 
respectively while 1 (10%) and 0 (0%) were resistant to manufacturer’s dilution and half the dilution of Jik respectively. 
 
The resistance demonstrated by some of the nosocomial agents in this study against the selected disinfectant formulations 
at their manufacturer’s dilution and half the prescribed dilutions showed the probability of the nosocomial agents 
developing some mechanisms of resistance against the various disinfectant formulations rather than ineffectiveness of the 
disinfectant formulations. However, the effectiveness of Jik formulation at half the manufacturer’s prescribed dilution 
shows that Jik is still an important disinfectant formulation in the control of nosocomial agent most especially the 
resistant strains.   
 
INTRODUCTION 
The term disinfectant is generally used for chemical agents 
employed to disinfect inanimate objects. They are use to 
reduce or eliminate pathogenic microbes in or on materials 
so that they are no longer a hazard. The process of using 
chemical disinfectants in inhibiting or killing pathogenic 
microorganisms is known as disinfection. Disinfection is 
however not an absolute term, this implies that some living 
microbes may persist but the possibility of sterilization 
resulting from disinfection cannot be ruled out (1, 22). 
Disinfectants used to treat skin and other external body 
membranes and cavities are termed Antiseptics (1, 22). 
 
There are various classes of chemical disinfectants, these 
are; Acids and their esters, Alcohols, Aldehydes, 
Biguanides, Halogens, Heavy metals, Oxidizing 
compounds, Phenols and Phenolic compounds, Surface 
active agents, Quinoline and Isoquinoline derivatives and 
Dyes, (1, 22). The choice of the most appropriate  
 
 
disinfectant formulation for a particular purpose depends 
on some factors like (1): 
- Properties of the chemical agent in terms of 
activity and solubility 
- Microbiological challenge in terms of types and 
level of microbial contamination 
- Intended application either for antiseptic or 
disinfection 
- Environmental factors such as presence of 
organic matter or specificity of microorganism to 
a particular environment 
- Toxicity of the agent i.e disinfectant toxicity 
effect. 
 
In the hospitals, disinfectants have been found to play an 
important role in the prevention and control of hospital 
acquired infections (Nosocomial infections). Nosocomial 
infections are those infections acquired in hospital or 
healthcare service unit that first appear 48 hours or more 
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after hospital admission or within 30 days after discharge 
following in-patient care (2).  
They are unrelated to the original illness that brings 
patients to the hospital and neither present nor incubating 
as at the time of admission (2, 3). Nosocomial agents could 
be bacteria, fungi, viruses and protozoan in nature (4). 
There are several reasons why nosocomial infections are 
more alarming than the community acquired infections; 
firstly, many medical procedures that bypass the body’s 
natural protective barriers could result into infecting the 
patients. Secondly, medical staffs move from patient to 
patient thus providing a way for pathogens to spread. 
Thirdly, inadequate sanitation protocols regarding 
uniforms, equipment sterilization, washing with 
disinfectant and other preventive measures that may either 
be unheeded by hospital personnel or too late to sufficiently 
isolate patients from infectious agents and lastly the routine 
use of antimicrobial agents especially the broad-spectrum 
antibiotics in hospitals creates selection pressure for the 
emergence of the resistant strains of microorganisms (2).  
 
The significance of nosocomial infection lies not only in its 
ability to substantially alter morbidity and mortality 
statistics, but also in its economic implications (5,6). 
Nosocomial infection prolongs duration of hospitalization, 
increases the cost of health care, emergence of multiple 
antibiotic resistance microorganisms and reduces the 
chances of treatment for others (7, 8, 9). 
 
In various hospitals, one of the ways among others, of 
controlling spread of infections within the hospital 
environment is the use of chemical disinfectant 
formulations in disinfecting the hospital environment and 
equipment, washing of hands when moving from patient to 
patient and after and disinfection of patient’s skin before 
injection, catheterization and operation is perform on them 
(19). However, failures in the antimicrobial activity of 
some of the disinfectants have been reported (1, 22). The 
utilization of phenolic constituent of some phenolic 
disinfectant as carbon source by some bacteria such as 
Pseudomonas aeruginosa and complete resistance of some 
microorganisms to some of the classes of disinfectants e.g. 
Staphylococcus aureus, are some of these reports (1, 22). 
The possibility of more microorganisms particularly the 
nosocomial bacteria further developing resistance to more 
of these disinfectant formulations, just like they do with 
antibiotics, underscore the need to constantly evaluate the 
antimicrobial activities of various chemical disinfectant 
formulations against the nosocomial agents. 
 
This study therefore, assesses the efficacy of some 
disinfectant formulations in Nigerian markets at their 
prescribed dilutions/concentrations of use by their 
manufacturers against some multidrug resistant bacteria of 
nosocomial origin. 
 
MATERIALS AND METHODOLOGY 
BACTERIOLOGY 
 The microorganisms used in this study were obtained on 
slants as pure culture from the microbiology unit of the 
University College Hospital (UCH) Ibadan, Oyo State from 
hospitalized patients who develop infection diagnosed to be 
acquired from the hospital environment. Ten 
microorganisms mainly bacteria were collected and used in 
this study. They include: Two strains of Pseudomonas 
aeruginosa (P1 and P2), Two strains of Staphylococcus 
aureus (S1 and S2) Two strains of Klebsiella species (K1 
and K2), Two strains of Proteus species (Pr1 and Pr2) and 
Two strains of Escherichia coli (E1 and E2). 
 
DETERMINATION OF ANTIBIOTIC 
SUSCEPTIBILITY PROFILES OF THE TEST 
CLINICAL ISOLATES USING STANDARD 
ANTIBIOTIC DISCS 
The standard disk diffusion method recommended by the 
National Committee for clinical laboratory standards 
(NCCLS, 2003) was used in determining bacterial 
susceptibility to antimicrobials as described by Qin et al in 
2004. The antibiotics used are Gentamicin, Cefixime, 
Ofloxacin, Ceftazidime, Augmentin, Nitrofurantoin, 
Ciprofloxacin, Cefuroxime, Erythromycin, Cloxacillin and 
Ceftriaxone. The standard antibiotic discs were placed at 
equal distance in a circular pattern on the surface of the 
Mueller Hinton agar with the aid of a sterile forcep. The 
antibiotic discs were designated differently for Gram 
positive and Gram negative organisms. The plates were 
then incubated at 37oC for 24hrs in an upside down 
position. The zones of growth inhibition were then 
recorded. 
 
PREPARATION OF THE TEST CONCENTRATIONS 
OF DISINFECTANT FORMULATIONS 
Two test dilutions each; of the three disinfectant 
formulations were prepared at a dilution a little below the 
dilutions prescribed for use by the manufacturers (e.i. 
higher concentrations). They were diluted to the test 
concentrations with sterile distilled water as stated below. 
- DETTOL (3%v/v and 6%v/v) 
- IZAL (0.5%v/v and 1%v/v) 
- JIK(SODIUM HYPOCHLORITE)  (2.5%v/v and 
5%v/v)  
 
ANTIMICROBIAL SCREENING OF THE 
DISINFECTANT FORMULATIONS 
 Using agar-cup diffusion method, two dilutions each, of 
the three test disinfectant formulations was used in this 
screening. Twenty millilitres of melted and cool Mueller 
Hinton agar was seeded with 0.2ml of 10-2 dilution from an 
overnight broth culture of the multidrug resistant strains of 
the test clinical isolates, rolled between palms and poured 
into sterile petri-dishes and allowed to set. The surface was 
then dried in a sterile drier and with the aid of a sterile 
8mm cup borer; five wells were bored into the agar plates. 
The first three wells were filled with two drops of the 
manufacturer’s dilutions for the three disinfectant 
formulations (3%v/v Dettol, 0.5%v/v Izal and 2.5%v/v Jik) 
and 10µg of Gentamicin was introduced into the fourth 
well as positive control while sterile distilled water was 
introduced into the fifth well as negative control. This 
procedure was also carried out for the corresponding half 
dilutions of the test disinfectant formulations (6%v/v 




 This whole process was done in duplicates. The plates 
after about one hour of pre-diffusion were then incubated at 
37oC for 24hrs in an upright position. The averages of the 
corresponding zones of growth inhibition were then 




The clinical isolates screened with some antibiotics namely 
Gentamicin, Cefixime, Ofloxacin, Ceftazidime, 
Augmentin, Nitrofurantoin, Ciprofloxacin, Cefuroxime, 
Erythromycin, Cloxacillin and Ceftriaxone shows that they 
were resistant to more than one class of the antibiotics 
used, making them multidrug resistant clinical strains. 
Proteus specie Pr1 was resistant to all the antibiotics except 
nitrofurantoin, Klebsiella specie K2, Pseudomonas 
aeruginosa P2, Escherichia coli E1 and Staphylococcus 
aureus S1 are resistant to all the antibiotics. Proteus specie 
Pr2 was susceptible only to ofloxacin, ciprofloxacin, 
nitrofurantion and cefixime, Klebsiella specie K1 to 
nitrofurantoin and gentamicin, Pseudomonas aeruginosa 
P1 to ofloxacin and ciprofloxacin while Streptococcus 
aureus S2 was susceptible to ofloxacin, ceftazidime, 
cefuroxime, gentamicin and ceftriaxone (Table 1). 
 
The susceptibility test for the three disinfectant 
formulations against the test clinical isolates shows that few 
of the test clinical isolates are resistant to some of the 
disinfectant formulations at a dilution below (i.e. higher 
concentration) the manufacturers prescribed dilutions as 
used in this study. Proteus specie Pr1, Pseudomonas 
aeruginosa P1 and Streptococcus aureus S2 were resistant 
to 3%v/v Dettol, 0.5%v/v and 1%v/v Izal. Streptococcus 
aureus S1 was resistant to 2.5%v/v Jik, 3%v/v Dettol and 
0.5%v/v Izal while Klebsiella specie K1 was resistant to the 
two dilutions of Dettol and Izal used in this study (Table 2). 
 
TABLE 1: ANTIBIOTIC SUSCEPTIBILITY PROFILE OF THE TEST CLINICAL ISOLATES 
 
 




Antibiotics zones of growth inhibition (mm) 
CXM OFL AUG NIT CPR CAZ CRX GEN 
Pr1 R R R 15 R R R R 
Pr2 17 15 R 12 20 R R R 
K1 R R R 23 R R R 14 
K2 R R R R R R R R 
E1 R R R R R R R R 
E2 R R R 24 R R R 15 
P1 R 25 R R 39 R R R 
P2 R R R R R R R R 
Gram positive organisms 
 
 ERY CXC OFL AUG CAZ CRX GEN CTR 
S1 R R R R R R R R 
S2 R R 30 R 20 15 15 25 
 
Key: 
CXM- CEFIXIME (5µg); OFL- OFLOXACIN (5µg); AUG- AUGMENTIN (30µg); NIT- NITROFURANTOIN (300µg);  
CPR- CIPROFLOXACIN (5 µg); CAZ- CEFTAZIDIME (30 µg); CRX- CEFUROXIME (30 µg)-; GEN- GENTAMICIN (10 µg);  









TABLE 2: ANTIMICROBIAL SUSCEPTIBILITY PATTERNS OF THE TEST DISINFECTANT FORMULATIONS AGAINST  





































































G (10µg/ml)  W 
 
Test Disinfectants zones of growth inhibition (mm) 
 
Pr1 R 13 R R 20 24 16 
- 
Pr2 18 20 R R 25 30 16 
- 
K1 R R R R 15 17 17 
- 
K2 13 13 R 13 14 17 17 
- 
E1 19 21 12 15 14 16 15 
- 
E2 16 16 R 12 14 15 15 
- 
P1 R 12 R R 13 15 R 
- 
P2 14 15 R R 12 14 16 
- 
S1 R 15 R 12 R 15 25 
- 
S2 R R R R 13 14 13 
- 
 
Keys: E- E. Coli; K- Klebsiella spp; S- Staphylococcus aureus; P- Pseudomonas aeruginosa; Pr- Proteus spp; G – Genticin;  
W – Water    - No activvity 
 
DISCUSSION 
All over the world, nosocomial infection is a recognized 
public health problem; Surveillance programmes estimate 
the rate of infection at 5-10% of hospital admissions (10, 
11, 12, 13). In Nigeria, nosocomial infection at a rate of 
2.7% was reported in Ife (15), while 3.8 % (14) was reported 
in Lagos and 4.2 % in Ilorin (16). These continue to increase 
yearly. Nosocomial infection rates vary substantially by 
body site, by type of hospital and by the infection control 
capabilities of the institution (17). Although viruses, fungi, 
bacteria and parasites are recognized as sources of 
nosocomial infections, bacterial agents remain the most 
commonly recognized cause (18).  
 
The emergent of multidrug resistant hospital acquired 
bacteria have been reported throughout the world and the 
mechanisms to which they resist the antimicrobial activity 
of the various antimicrobial agents particularly antibiotics 
have also been studied extensively (22). However, such 
studies have not been adequately done for most of the 
classes of disinfectants in Nigeria. The development of  
 
 
resistance to the Phenolic class has long been reported (22). 
Some microorganisms, for example, Pseudomonas 
aeruginosa, have been found to utilize some phenolic 
compounds as their carbon source (1, 22).  
 
In this study, the presence of multidrug resistance bacteria 
nosocomial agents was observed as all the clinical isolates 
used in this study were found to be multidrug resistant 
(100% prevalence). Resistance was observed with some of 
the clinical isolates being resistant to the disinfectant 
formulations at the dilution prescribed by their 
manufacturers. Proteus specie (Pr1), Klebsiella specie 
(K1), Pseudomonas aeruginosa (P1), and Staphylococcus 
aureus (S1 and S2) were resistant to 3%v/v Dettol and 
0.5%v/v Izal while Staphylococcus aureus (S1) was 
resistant to 2.5%v/v Jik. Proteus specie (Pr2), Klebsiella 
specie (K2), Escherichia coli (E2) and Pseudomonas 
aeruginosa (P2) were resistant to 0.5%v/v Izal. However, 
some became susceptible when the disinfectants were 
diluted at half the prescribed dilution i.e higher 
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concentration than the prescribed concentrations. Proteus 
specie (Pr1 and Pr2), Klebsiella specie (K1), Pseudomonas 
aeruginosa (P1 and P2) and Staphylococcus aureus (S2) 
remained resistant to the Izal formulation when the dilution 
was lowered to half the prescribed dilution (1%v/v) while 
Klebsiella specie (K1) and Staphylococcus aureus (S2) 
remained resistant to 6%v/v of Dettol formulation.  
 
All the clinical isolates were susceptible to Jik formulation 
when the dilution was lowered to half that of the prescribed 
dilution i.e higher concentration of 5%v/v. This shows that 
Jik disinfectant formulation stand as an effective 
disinfectant formulation against nosocomial agent 
particularly the multidrug resistant strains of bacteria when 
used at a much lower dilution (i.e. higher concentration) to 
that prescribed by the manufacturer. 
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